Cancer Clinics of Excellence

News and Events

• 

  Cancer Clinics of Excellence Fall Meeting and Clinical Retreat

  September 19-21 2013, Washington, DC
  
  Click here for more information
• 
  Editor-in-Chief Dr. David Henry highlights articles on T-DM1 for advanced HER2-positive breast cancer and an original research report from US Oncology on treatment patterns in women with HER2-/HR-positive breast cancer.
  
  
• 
  Dr. Nicholas Vogelzang talks to CCE member Dr. David Henry, Editor in Chief of COMMUNITY ONCOLOGY, about how he treats patients with metastatic prostate cancer, given the new agents that are now available, and growing concerns about treament costs and patient quality of life.
  
• 

  Combination myeloma therapy almost doubles PFS

  Community Oncology editor Dr. David Henry spoke with Dr. Kenneth Anderson at the Oncology Practice Summit in Las Vegas about the antibody elotuzumab in the treatment of relapsed or refractory multiple myeloma.
• 

  CCE and Accretive Health Announce Strategic Partnership

  Firms to develop novel oncology care management solution Accretive Health, Inc. (NYSE:AH), a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.